Resolor ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
51Scleroderma1

51. Scleroderma


Clinical trials : 523 Drugs : 608 - (DrugBank : 156) / Drug target genes : 114 - Drug target pathways : 215
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2012-005348-92-IT
(EUCTR)
19/02/201311/01/2013PROGASS PRucalopride On the GAstreonteric transit in Systemic SclerosisPROGASS PRucalopride On the GAstreonteric transit in Systemic Sclerosis - PROGASS Sysemic sclerosis with gastroenteric involvement (constipation)
MedDRA version: 14.1;Level: SOC;Classification code 10017947;Term: Gastrointestinal disorders;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Trade Name: RESOLOR*28CPR RIV 2MG
INN or Proposed INN: PRUCALOPRIDE SUCCINATE
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANONULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: no
Italy